Company
Epicrispr Biotechnologies
Regulate any gene, anywhere
Also known as Epicrispr Biotechnologies, Inc.
- Status
- Operatingas of 2026-09-17
- Employees
- 40-person companySource (opens in a new tab)
- Legal name
- Epicrispr Biotechnologies, Inc.
- epicrispr.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Developing therapies to dynamically control gene expression and treat complex disease
Funding snapshot
- Total raised
- $90MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series C, $90M2026-08-11
Funding rounds
- Series C
- $90M2026-08-11, Company stated
- Round, 2018
- $177M2018-05-04, SEC form D sold, 47 investors
Loading relationship preview